Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 26, 2022 17:00 ET | Source: Alvotech

Alvotech tekur þátt í heilbrigðisráðstefnu Jefferies í London í nóvember 2022

Alvotech (NASDAQ First North: ALVO) tilkynnti í dag að fulltrúar yfirstjórnar Alvotech muni taka þátt í heilbrigðisráðstefnu Jefferies í London, 15.–17. nóvember n.k. Gert er ráð fyrir að...
October 26, 2022 17:00 ET | Source: Alvotech

Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November

Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will...
October 26, 2022 17:00 ET | Source: Alvotech

Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November

REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide,...
October 19, 2022 05:00 ET | Source: Alvotech

Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care

Expanded partnership covers biosimilar candidates in immunology and oncology REYKJAVIK, Iceland and BOUCHERVILLE, Quebec, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global...
October 19, 2022 05:00 ET | Source: Alvotech

Alvotech og JAMP Pharma fjölga samstarfsverkefnum til að bæta aðgengi að líftæknilyfjum í Kanada

Tveimur fyrirhuguðum líftæknilyfjahliðstæðum Alvotech fyrir sjúklinga með sjálfsofnæmissjúkdóma og krabbamein er bætt við samstarfssamninginn Alvotech (NASDAQ First North: ALVO) og JAMP Pharma...
October 19, 2022 05:00 ET | Source: Alvotech

Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care

Expanded partnership covers biosimilar candidates in immunology and oncology Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar...
October 17, 2022 05:00 ET | Source: Alvotech

Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization partner...
October 17, 2022 05:00 ET | Source: Alvotech

Samstarfsaðili Alvotech sækir um markaðsleyfi fyrir fyrstu líftæknilyfjahliðstæðuna í Japan

Alvotech (NASDAQ First North: ALVO) tilkynnti í dag að samstarfsaðili þess, Fuji Pharma Co., Ltd. (“Fuji”) hafi sótt um leyfi til japanska heilbrigðis-, atvinnu- og velferðarráðuneytisins til...
October 17, 2022 05:00 ET | Source: Alvotech

Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan

REYKJAVIK, Iceland, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
October 11, 2022 17:00 ET | Source: Alvotech

Alvotech Appoints Sarah Tanksley as Chief Quality Officer

REYKJAVIK, Iceland, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...